5-[(4-羧基苯基)亚甲基]-2-硫氧-3- [(3-三氟甲基)苯基-4-噻唑烷酮

CFTR 抑制剂
  • 10mM in DMSO
有货

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
C408961-1ml
1ml 现货 Stock Image
查看相关系列
Compound libraries (12332)

基本描述

英文别名 CFTR inhibitor 172 | Benzoic acid, 4-[[4-oxo-2-thioxo-3-[3-(trifluoromethyl)phenyl]-5-thiazolidinylidene]methyl]-
规格或纯度 10mM in DMSO
英文名称 CFTRinh-172
生化机理 CFTRinh-172 (CFTR 抑制剂 172)是一种与电压无关的选择性 CFTR 抑制剂,Ki为 300 nM,对 MDR1、ATP 敏感的 K+ 通道或一系列其他转运体没有影响。
储存温度 -80℃储存
运输条件 超低温冰袋运输
产品介绍

产品应用:
CFTR(inh)-172用于特异性抑制囊性纤维化跨膜电导调节因子(CFTR)的活性。也可用作 CFTR抑制剂 Inh-172处理福司柯林(毛喉素)和IBMX。

Information

CFTRinh-172 CFTRinh-172 (CFTR inhibitor 172) is a voltage-independent, selective CFTR inhibitor with K i of 300 nM, showing no effects on MDR1, ATP-sensitive K+ channels, or a series of other transporters.
In vitro

CFTRinh-172 dose- and time-dependently inhibits CFTR-mediated I- transportation, and effectively inhibits CFTR activation by multiple types of agonists or activators. CFTRinh-172, as a selective CFTR channel inhibitor, also completely abolishes the Cl current in the rabbit acinar and duct cells of rabbit lacrimal gland. CFTRinh-172 also induces ROS production, mitochondrial failure, and activation of the NF-κB signaling pathway, independently of CFTR inhibition.

In vivo

CFTRinh-172 (20 µg/6 h) completely abolishes the V. cholerae-induced intestinal fluid secretion without affecting V. cholerae growth in vivo.
Cell Data

cell lines:Rheumatoid arthritis synovial fibroblast(s)

Concentrations:~1 mM

Incubation Time:24 hours

Powder Purity:≥99%

关联靶点(人)

CFTR Tclin 囊性纤维化跨膜传导调节器(Cystic fibrosis transmembrane conductance regulator) (3 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

名称和识别符

分子类型 小分子
Canonical SMILES OC(=O)C1=CC=C(C=C1)\C=C/2SC(=S)N(C2=O)C3=CC=CC(=C3)C(F)(F)F
分子量 409.4

安全和危险性(GHS)

技术规格说明书

Concentration 9-11(mmol/L)
Proton NMR spectrum Conforms to Structure

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

溶液计算器

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.